CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Common Shares [Member]	Additional Paid-In Capital [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive (Loss)/Income [Member]	Total	Cumulative Effect, Period of Adoption, Adjustment [Member] Retained Earnings [Member]	Cumulative Effect, Period of Adoption, Adjustment [Member]
Balance at Dec. 31, 2023	$ 7	$ 36,852	$ 525,360	$ (12,464)	$ 549,755	$ 40	$ 40
Balance (in shares) at Dec. 31, 2023	747,971
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible Enumeration]						us-gaap:AccountingStandardsUpdate202302Member	us-gaap:AccountingStandardsUpdate202302Member
Net income	$ 0	0	22,723	0	22,723
Other comprehensive income (loss), net of tax	0	0	0	(1,850)	(1,850)
Repurchase of common stock	$ 0	(5,451)	0	0	(5,451)
Repurchase of common stock (in shares)	(5,201)
Balance at Mar. 31, 2024	$ 7	31,401	548,123	(14,314)	565,217
Balance (in shares) at Mar. 31, 2024	742,770
Balance at Dec. 31, 2024	$ 7	0	592,431	(19,366)	$ 573,072
Balance (in shares) at Dec. 31, 2024	699,798				699,798
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	$ 0	0	23,009	0	$ 23,009
Other comprehensive income (loss), net of tax	$ 0	0	0	4,894	4,894
Stock Issued During Period, Shares, Restricted Stock Award, Gross	30,818
Stock Issued During Period, Value, Restricted Stock Award, Gross	$ 0				0
Stock based compensation expense	0	2,042	0	0	2,042
Repurchase of common stock	$ 0	0	(711)	0	(711)
Repurchase of common stock (in shares)	(703)
Balance at Mar. 31, 2025	$ 7	$ 2,042	$ 614,729	$ (14,472)	$ 602,306
Balance (in shares) at Mar. 31, 2025	729,913				729,913